LeMaitre Vascular to Present at Upcoming Investor Conferences

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced participation in two upcoming investor conferences in August 2020. CFO JJ Pellegrino will present at the virtual Canaccord Genuity 40th Annual Growth Conference on August 13 at 8:00 AM EDT. Additionally, President David Roberts will attend the virtual 5th Annual Needham Med Tech & Diagnostics 1×1 Conference on August 17. LeMaitre Vascular specializes in devices and services for peripheral vascular disease, which affects over 200 million people globally, offering a diverse range of vascular devices for surgeons.

BURLINGTON, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, at 8:00 AM EDT.

David Roberts, President, is scheduled to participate in the virtual 5^th Annual Needham Med Tech & Diagnostics 1×1 Conference on Monday, August 17, 2020.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:  LeMaitre Vascular, Inc.
Sandra Millar
+1-781-425-1686

FAQ

When and where is LeMaitre Vascular presenting in August 2020?

LeMaitre Vascular will present at the virtual Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 8:00 AM EDT.

Who will represent LeMaitre Vascular at the Needham Conference?

David Roberts, the President of LeMaitre Vascular, will participate in the virtual 5th Annual Needham Med Tech & Diagnostics 1×1 Conference on August 17, 2020.

What is the focus of LeMaitre Vascular's product line?

LeMaitre Vascular provides devices and services for treating peripheral vascular disease, addressing the needs of vascular surgeons.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people around the world.

What is the stock symbol for LeMaitre Vascular?

The stock symbol for LeMaitre Vascular is LMAT.